Skip to main content Skip to footer

Orexo press releases

Notice of Annual General Meeting of Orexo

12 March 2013 at 11:00 – RegulatoryGeneral Meeting

Notice of Annual General Meeting of Orexo

Number of shares and votes in Orexo

28 February 2013 at 16:30 – Regulatory

Number of shares and votes in Orexo

Agreement with Novartis on OX17 for GERD terminated

25 February 2013 at 08:00 – Regulatory

Agreement with Novartis on OX17 for GERD terminated

Number of shares and votes in Orexo

31 January 2013 at 16:30 – Regulatory

Number of shares and votes in Orexo

Interim report, January-December 2012

31 January 2013 at 08:00 – RegulatoryReportQ4

Interim report, January-December 2012

Number of shares and votes in Orexo

28 December 2012 at 16:00 – Regulatory

Number of shares and votes in Orexo

Number of shares and votes in Orexo

30 November 2012 at 16:30 – Regulatory

Number of shares and votes in Orexo

Number of shares and votes in Orexo

31 October 2012 at 16:30 – Regulatory

Number of shares and votes in Orexo

Interim report, January-September 2012

25 October 2012 at 08:00 – RegulatoryReportQ3

Interim report, January-September 2012

Number of shares and votes in Orexo

28 September 2012 at 16:30 – Regulatory

Number of shares and votes in Orexo

Orexo halts share buyback due to upcoming Q3 interim report

21 September 2012 at 08:00 – Regulatory

Orexo halts share buyback due to upcoming Q3 interim report

IR & Corporate Communications Director

Lena Wange

Subscribe